Walnut-Derived Peptides Ameliorate Scopolamine-Induced Memory Impairments in a Mouse Model via Activation of Peroxisome Proliferator-Activated Receptor γ-Mediated Excitotoxicity.
Yue ShenQiao DangLi FangDan WuYanru LiFanrui ZhaoChunlei LiuWeihong MinPublished in: Journal of agricultural and food chemistry (2024)
We investigated the protective effect of walnut peptides and YVPFPLP (YP-7) on scopolamine-induced memory impairment in mice and β-amyloid (Aβ)-induced excitotoxic injury in primary hippocampal neurons, respectively. Additionally, the protective mechanism of YP-7 on neuronal excitotoxicity was explored. Mouse behavioral and hippocampal slice morphology experiments indicate that YP-7 improves the learning and memory abilities of cognitively impaired mice and protects synaptic integrity. Immunofluorescence, western blotting, and electrophysiological experiments on primary hippocampal neurons indicate that YP-7 inhibits neuronal damage caused by excessive excitation of neurons induced by Aβ. HT-22 cell treatment with peroxisome proliferator-activated receptor γ (PPARγ) activators and inhibitors showed that YP-7 activates PPARγ expression and maintains normal neuronal function by forming stable complexes with PPARγ to inhibit the extracellular regulated protein kinase pathway. Therefore, YP-7 can ameliorate glutamate-induced excitotoxicity and maintain neuronal signaling. This provides a theoretical basis for active peptides to ameliorate excitotoxicity and the development of functional foods.
Keyphrases
- high glucose
- cerebral ischemia
- diabetic rats
- mouse model
- spinal cord
- insulin resistance
- protein kinase
- working memory
- drug induced
- oxidative stress
- magnetic resonance
- magnetic resonance imaging
- fatty acid
- cell therapy
- brain injury
- physical activity
- adipose tissue
- stem cells
- transcription factor
- high fat diet induced
- single cell
- subarachnoid hemorrhage
- high resolution
- temporal lobe epilepsy
- replacement therapy